Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 143 publications
Erratum: Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 31, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.
Journal: Nature medicine
Published: May 16, 2025
Editorial Expression of Concern: E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells.
Journal: Cancer gene therapy
Published: December 05, 2024
Peritoneal Immunosurgery: Immunotherapy Augmented Surgery for the Treatment of Peritoneal Cancers.
Journal: Journal of surgical oncology
Published: September 03, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 21, 2024
Eighteen-year survival after GD2-directed Chimeric Antigen Receptor-Modified Immune Effector Cell Treatment for Neuroblastoma.
Journal: Research square
Published: April 25, 2024
IL-12 encoding oNDV synergizes with CAR-T cells in orthotopic models of non-small cell lung cancer.
Journal: Molecular therapy. Oncology
Published: April 23, 2024
Interleukin-15-armored GPC3-CAR T cells for patients with solid cancers.
Journal: Research square
Published: April 22, 2024
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma.
Journal: Nature medicine
Published: April 07, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.
Journal: Nature
Published: March 14, 2024
Mesenchymal stromal cells protect combined oncolytic and helper-dependent adenoviruses from humoral immunity.
Journal: Molecular therapy. Methods & clinical development
Published: February 26, 2024
Bispecific antibodies and autologous chimeric antigen receptor T cell therapies for treatment of hematological malignancies.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: January 30, 2024
Last Updated: 09/26/2026